• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敏感和耐药的恶性疟原虫株通过休眠来耐受高浓度的氯喹,但长时间暴露后会被清除。

Chloroquine-susceptible and -resistant Plasmodium falciparum strains survive high chloroquine concentrations by becoming dormant but are eliminated by prolonged exposure.

机构信息

Projecto de Saúde de Bandim, Indepth Network, Bissau, Guinea-Bissau.

Department of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden.

出版信息

J Antimicrob Chemother. 2022 Mar 31;77(4):1005-1011. doi: 10.1093/jac/dkac008.

DOI:10.1093/jac/dkac008
PMID:35137072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8969533/
Abstract

BACKGROUND

Plasmodium falciparum strains that are resistant to standard-dose chloroquine can be treated by higher chloroquine concentrations maintained for a longer time in vivo.

OBJECTIVES

To determine the relative importance of chloroquine concentrations versus exposure time for elimination of chloroquine-susceptible and -resistant P. falciparum in vitro.

METHODS

Chloroquine-susceptible (3D7) and -resistant (FCR3) strains were exposed in vitro to 1, 2, 4, 8, 16 or 32 times their respective 90% inhibitory chloroquine concentrations for 3, 5, 7 or 14 days and then followed until recrudescence, or not, by 42 days after the end of exposure.

RESULTS

Exposure to chloroquine appeared to eliminate susceptible and resistant parasites, leaving small pyknotic apparently dead parasites. Chloroquine-susceptible and -resistant parasites recrudesced after 3 and 5 days of chloroquine exposure. Recrudescence occurred in one out of four 7 day exposure series but not after 14 days exposure. The median time to recrudescence was 13 to 28 days with a range of 8 to 41 days after the end of exposure. Time to recrudescence after the end of exposure increased with duration of exposure for susceptible and resistant strains (P < 0.001). Time to recrudescence did not correlate with concentrations greater than 1× IC90.

CONCLUSIONS

Chloroquine-susceptible and -resistant P. falciparum probably become dormant. Elimination of dormant parasites is primarily dependent upon the duration of chloroquine exposure. Exposure to effective drug concentrations for 7 days eliminates most parasites in vitro. The results support in vivo data indicating that elimination of chloroquine-resistant P. falciparum correlates with Day 7 chloroquine concentrations.

摘要

背景

对标准剂量氯喹有抗性的恶性疟原虫菌株可以通过在体内维持更高的氯喹浓度和更长的时间来治疗。

目的

确定氯喹浓度与暴露时间对体外消除氯喹敏感和耐药恶性疟原虫的相对重要性。

方法

将氯喹敏感(3D7)和耐药(FCR3)株分别在体外暴露于其各自 90%抑制氯喹浓度的 1、2、4、8、16 或 32 倍,持续 3、5、7 或 14 天,然后在暴露结束后 42 天内观察是否复发。

结果

暴露于氯喹似乎可以消除敏感和耐药寄生虫,留下小的固缩,显然是死亡的寄生虫。氯喹敏感和耐药寄生虫在氯喹暴露 3 天和 5 天后复发。在 4 个 7 天暴露系列中有 1 个发生复发,但在 14 天暴露后没有复发。复发的中位时间为暴露结束后 13 至 28 天,范围为 8 至 41 天。暴露结束后,敏感和耐药株的复发时间随暴露时间的延长而增加(P<0.001)。复发时间与大于 1×IC90 的浓度无关。

结论

氯喹敏感和耐药恶性疟原虫可能处于休眠状态。休眠寄生虫的消除主要取决于氯喹暴露的持续时间。在体外,暴露于有效药物浓度 7 天可消除大多数寄生虫。结果支持体内数据表明,氯喹耐药恶性疟原虫的消除与第 7 天氯喹浓度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ee/8969533/faede96d0a53/dkac008f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ee/8969533/4286b4566798/dkac008f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ee/8969533/318433797352/dkac008f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ee/8969533/faede96d0a53/dkac008f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ee/8969533/4286b4566798/dkac008f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ee/8969533/318433797352/dkac008f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ee/8969533/faede96d0a53/dkac008f3.jpg

相似文献

1
Chloroquine-susceptible and -resistant Plasmodium falciparum strains survive high chloroquine concentrations by becoming dormant but are eliminated by prolonged exposure.敏感和耐药的恶性疟原虫株通过休眠来耐受高浓度的氯喹,但长时间暴露后会被清除。
J Antimicrob Chemother. 2022 Mar 31;77(4):1005-1011. doi: 10.1093/jac/dkac008.
2
Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.越南中南部宁顺省福川乡恶性疟原虫对青蒿素类药物的敏感性和间日疟原虫对氯喹的敏感性。
Malar J. 2019 Jan 17;18(1):10. doi: 10.1186/s12936-019-2640-2.
3
Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites.马拉维对氯喹敏感的恶性疟原虫的卷土重来是多种敏感寄生虫的重新扩张。
J Infect Dis. 2010 Sep 1;202(5):801-8. doi: 10.1086/655659.
4
Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993.1990 - 1993年巴布亚新几内亚马当省恶性疟原虫疟疾对阿莫地喹、氯喹和奎宁的耐药性
P N G Med J. 1996 Mar;39(1):16-22.
5
In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine.用异丙嗪在体外和体内逆转恶性疟原虫对氯喹的耐药性。
Am J Trop Med Hyg. 1998 May;58(5):625-9. doi: 10.4269/ajtmh.1998.58.625.
6
High-Dose Chloroquine for Treatment of Chloroquine-Resistant Plasmodium falciparum Malaria.高剂量氯喹治疗氯喹耐药性恶性疟原虫疟疾
J Infect Dis. 2016 Apr 15;213(8):1315-21. doi: 10.1093/infdis/jiv590. Epub 2015 Dec 11.
7
Molecular epidemiology of malaria in cameroon. IX. Characteristics of recrudescent and persistent Plasmodium falciparum infections after chloroquine or amodiaquine treatment in children.喀麦隆疟疾的分子流行病学。IX. 儿童接受氯喹或氨酚喹治疗后恶性疟原虫复发和持续感染的特征。
Am J Trop Med Hyg. 2002 Feb;66(2):117-23. doi: 10.4269/ajtmh.2002.66.117.
8
Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: A systematic review.在撒哈拉以南非洲国家停止使用氯喹治疗单纯性疟疾后,对氯喹耐药恶性疟原虫的分子监测:一项系统评价。
J Infect Public Health. 2022 May;15(5):550-557. doi: 10.1016/j.jiph.2022.03.015. Epub 2022 Mar 29.
9
Correlation between in vitro and in vivo antimalarial activity of compounds using CQ-sensitive and CQ-resistant strains of Plasmodium falciparum and CQ-resistant strain of P. yoelii.使用恶性疟原虫的氯喹敏感和氯喹耐药菌株以及约氏疟原虫的氯喹耐药菌株对化合物的体外和体内抗疟活性之间的相关性。
Parasitol Res. 2017 Jul;116(7):1849-1854. doi: 10.1007/s00436-017-5455-5. Epub 2017 May 13.
10
Molecular epidemiology of malaria in Yaounde, Cameroon V. analysis of the omega repetitive region of the plasmodium falciparum CG2 gene and chloroquine resistance.喀麦隆雅温得疟疾的分子流行病学 V. 恶性疟原虫CG2基因ω重复区域分析与氯喹抗性
Am J Trop Med Hyg. 1999 Nov;61(5):807-13. doi: 10.4269/ajtmh.1999.61.807.

引用本文的文献

1
Isolation and characterization of blood-stage persisters by improved selection protocols using dihydroartemisinin alone.通过仅使用双氢青蒿素的改进选择方案对血液阶段持续存在的疟原虫进行分离和鉴定。
Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0005324. doi: 10.1128/aac.00053-24. Epub 2025 Feb 10.
2
Progressive heterogeneity of enlarged and irregularly shaped apicoplasts in persister blood stages after drug treatment.药物治疗后持续性血液阶段中增大且形状不规则的顶质体的渐进性异质性。
PNAS Nexus. 2024 Sep 24;3(10):pgae424. doi: 10.1093/pnasnexus/pgae424. eCollection 2024 Oct.
3
Magneto-optical assessment of Plasmodium parasite growth via hemozoin crystal size.

本文引用的文献

1
High-Dose Chloroquine for Uncomplicated Plasmodium falciparum Malaria Is Well Tolerated and Causes Similar QT Interval Prolongation as Standard-Dose Chloroquine in Children.高剂量氯喹治疗无并发症恶性疟原虫疟疾耐受性良好,且引起的 QT 间期延长与儿童标准剂量氯喹相似。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01846-19.
2
Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam.单一多重耐药疟原虫谱系(PfPailin)传播至越南。
Lancet Infect Dis. 2017 Oct;17(10):1022-1023. doi: 10.1016/S1473-3099(17)30524-8.
3
Malaria parasite clearance.
基于血晶尺寸的疟原虫生长的磁光评估。
Sci Rep. 2024 Jun 21;14(1):14318. doi: 10.1038/s41598-024-60988-6.
4
Progressive heterogeneity of enlarged and irregularly shaped apicoplasts in persister blood stages after drug treatment.药物治疗后持续性血液阶段中增大且形状不规则的顶质体的渐进性异质性。
bioRxiv. 2024 Aug 29:2024.01.03.574077. doi: 10.1101/2024.01.03.574077.
疟原虫清除
Malar J. 2017 Feb 23;16(1):88. doi: 10.1186/s12936-017-1731-1.
4
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.大湄公河次区域青蒿素耐药恶性疟原虫的传播:一项分子流行病学观察性研究。
Lancet Infect Dis. 2017 May;17(5):491-497. doi: 10.1016/S1473-3099(17)30048-8. Epub 2017 Feb 2.
5
High-Dose Chloroquine for Treatment of Chloroquine-Resistant Plasmodium falciparum Malaria.高剂量氯喹治疗氯喹耐药性恶性疟原虫疟疾
J Infect Dis. 2016 Apr 15;213(8):1315-21. doi: 10.1093/infdis/jiv590. Epub 2015 Dec 11.
6
Mitochondrial Membrane Potential in a Small Subset of Artemisinin-Induced Dormant Plasmodium falciparum Parasites In Vitro.体外青蒿素诱导休眠疟原虫小部分中的线粒体膜电位。
J Infect Dis. 2015 Aug 1;212(3):426-34. doi: 10.1093/infdis/jiv048. Epub 2015 Jan 29.
7
Temporal and seasonal changes of genetic polymorphisms associated with altered drug susceptibility to chloroquine, lumefantrine, and quinine in Guinea-Bissau between 2003 and 2012.2003年至2012年期间几内亚比绍与氯喹、卤泛群和奎宁药物敏感性改变相关的基因多态性的时间和季节变化。
Antimicrob Agents Chemother. 2015 Feb;59(2):872-9. doi: 10.1128/AAC.03554-14. Epub 2014 Nov 24.
8
Fatty acid synthesis and pyruvate metabolism pathways remain active in dihydroartemisinin-induced dormant ring stages of Plasmodium falciparum.脂肪酸合成和丙酮酸代谢途径在双氢青蒿素诱导的恶性疟原虫休眠环状体阶段仍保持活跃。
Antimicrob Agents Chemother. 2014 Aug;58(8):4773-81. doi: 10.1128/AAC.02647-14. Epub 2014 Jun 9.
9
Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporter.多种突变途径通过疟原虫的氯喹耐药转运蛋白汇聚到可饱和的氯喹转运上。
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):E1759-67. doi: 10.1073/pnas.1322965111. Epub 2014 Apr 11.
10
Chloroquine is grossly under dosed in young children with malaria: implications for drug resistance.氯喹在患疟疾的幼儿中严重剂量不足:对耐药性的影响。
PLoS One. 2014 Jan 23;9(1):e86801. doi: 10.1371/journal.pone.0086801. eCollection 2014.